中文 | English
Return
Total: 25 , 1/3
Show Home Prev Next End page: GO
Author:( Yingyi LU)

1.Influence factors and strategies of anti-VEGF therapy for wet AMD

Hong, DAI ; Yingyi, LU

Chinese Journal of Experimental Ophthalmology 2016;34(1):1-4

2.Choice of current approaches to the management of diabetic macular edema

Hong, DAI ; Yingyi, LU

Chinese Journal of Experimental Ophthalmology 2016;34(12):1061-1064

3.Overall assessment of the factors influencing the effect of anti-vascular endothelial growth factor for neovascular age-related macular degeneration to improve the comprehensive benefit of treatment

Hong DAI ; Yingyi LU

Chinese Journal of Ocular Fundus Diseases 2016;32(1):8-11

4.Visual function before and after photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration

Qun XIA ; Yingyi LU ; Xiaobing YU

Chinese Journal of Ocular Fundus Diseases 2003;0(05):-

5.Macular light sensibility in idiopathic epiretinal membrane measured by scanning laser ophthalmoscope

Yingyi LU ; Hong DAI ; Qun XIA

Chinese Journal of Ocular Fundus Diseases 1999;0(02):-

6.Detect PEDF mRNA by RT-PCR in Experimental Choroidal Neovascularization Induced by Krypton Laser

Tong CHEN ; Xioaxiong WANG ; Yingyi LU

Journal of Medical Research 2006;0(06):-

7.Effect of phacoemulsification versus extracapsular cataract extraction in patients with intumescent senile cataract

Zheng WANG ; Yingyi LU ; Guang LU ; Tong CHEN

Chinese Journal of Geriatrics 2014;33(3):290-293

8.Analysis of factors associated with vision and hole closure for idiopathic macular hole after vitrectomy surgery

Shuang SONG ; Xiaoya GU ; Yingyi LU ; Xiaobing YU ; Hong DAI

Chinese Journal of Ocular Fundus Diseases 2017;33(4):346-349

9.Study on experimental choroidal neovascularization inhibition with intravitreal bevacizumab injection

Tong CHEN ; Yingyi LU ; Mingshun LI ; Hong DAI

Chinese Journal of Geriatrics 2008;27(5):385-388

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 25 , 1/3 Show Home Prev Next End page: GO